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Menstruating females seem to bleed more when they ingest sugar or sugar containing substances. This 
study was carried out to determine the effect of acute hyperglycemia on clotting time and relative plasm  
viscosity during menstruation. Forty menstruating females from the St. Philomena School of Midwifery, Benin, 
Nigeria volunteered for the study. following ethical approval from St. Philomena Catholic Hospital, blood 
samples were collected from the ante cubital vein; pre-ingestion, one hour and two hours post ingestion of 
glucose concentrations    (39 g/200ml, 78 g/200ml). Fasting blood samples and post glucose ingestion blood 
samples were analyzed for Sugar, Clotting time and Relative Plasma Viscosity (RPV) using Standard 
laboratory methods. Results were analyzed with paired t-t st and values of p<0.05 were considered statistically 
significant. The result showed a statistically significant increase (p<0.05) in clotting time and a decrease in 
relative plasma viscosity (p<0.05) one hour after the intake of both glucose concentrations. Two hours after 
glucose intake, there was a decrease in clotting time owards the baseline and an increase in RPV towards the 
baseline. This study thus suggests that acute hypergl c mia increases clotting time and reduced RPV in 
menstruating girls. This may be the reason for the perceived sense of increased menstrual flow. 
© 2015 International Formulae Group. All rights reserved. 
 




Menstruation results from a complex 
interaction between the hypothalamus, the 
anterior pituitary gland, the ovaries and uterus 
(Guyton and Hall, 2006) and it typically 
indicates that fertilization did not occur. In the 
absence of pregnancy, the fall of plasma 
progesterone concentration due to corpus 
luteum involution triggers menstrual 
endometrium remodeling, leading to shedding 
of its functional layer associated with bleeding 
(Pauline et al., 2013).  This desquamation is 
linked and controlled by cyclical fluctuations 
in the levels of follicle stimulating hormone, 
luteinizing hormone, estrogen and 
progesterone. However, despite this intrinsic 
hormonal effect, extrinsic factors such as diet 
and life style can still influence menstrual 
flow and cycle. Studies have shown that non-
modifiable host factors such as ethnicity and 
potentially modifiable risk factors such as 
smoking, physical activity and alcohol may 
affect menstrual cycle outcome (Liu et al., 
2004). Dieting, a self-induced attempt to 
restrict food consumption can result to low 
serum leptin and in extreme cases of dieting 
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such as anorexia nervosa there can be 
disturbance of ovulatory function and 
abnormal menstrual cycle (Franca et al., 
2000). Furthermore, stress and overwhelming 
fluctuation in weight and has been found to 
affect menstruation. During stress, the 
increased secretion of cortisol causes 
functional menstrual abnormalities (Loucks 
and Redman, 2004). Functional menstrual 
abnormalities such as delayed or reduced flow 
menstrual flow are traceable to the decreased 
release of estrogen and progesterone 
occasioned by the increased secretion of 
cortisol.   
Clotting time which is the required for 
clot formation is one of the tests carried out 
during blood coagulation test, in addition to 
bleeding time and thrombin time. Coagulation 
involves both cellular (platelet) and protein 
(coagulation factor) component (Furie and 
Furie 2005) i.e it involves the intrinsic and 
extrinsic pathway with both occurring 
simultaneously. Tissue factor initiates the 
extrinsic pathway whereas the contact of 
factor XII (Hageman factor) and platelet with 
collagen in the vascular wall initiates the 
intrinsic pathway. Clot begins to form about 
15-20 seconds later, if the trauma to the 
vascular wall is severe and 1-2 minutes if it is 
not severe (Guyton and Hall, 2006). As the 
bleeding time is correlated with the platelet 
levels, studies show that during menstrual 
phase, platelet count decreased and bleeding 
time increased, whereas around mid-cycle 
platelet count increased and bleeding time 
decreased (Rajnee et al., 2010). Earlier studies 
have shown that increase intake of glucose 
increases clotting time (Moreno et al., 2000). 
Plasma viscosity is essentially a measure of 
plasma protein changes, its level can change 
in parallel with fibrinogen, especially in acute 
phase response (e.g., in acute ischemic 
events), but can also be influenced by the 
level of triglycerides (Gabor et al., 2008). 
Relative plasma viscosity is the flow rate of 
plasma relative to the flow rate of distilled 
water (Reid and Ugwu, 1987).  It has been 
shown that blood viscosity and plasma 
viscosity decreases during menstruation and 
peak at about 7th and 21st day respectively, 
but fibrinogen which is the major determinant 
of plasma viscosity is found to be higher 
during menstruation (Dapper and Dida., 
2002). Increase in blood glucose has been 
shown to increase relative plasma viscosity in 
diabetic patients (Olatunji et al., 2008) i.e. 
diabetes is a procoagulable state. This study is 
aimed at determining the effect of ingestion of 
varying concentrations glucose on clotting 
time and relative plasma viscosity during 
menstruation, in a view to assessing the 
impact of sugar on the intensity of bleeding 
during menstruation. 
  
MATERIALS AND METHODS 
Forty menstruating subjects between 
the ages of 18 and 25 from the St Philomena 
School of Mid-wifery in Benin City, Nigeria 
volunteered for the study. Demographic and 
menstrual cycle data were obtained by using a 
semi-structured questionnaire. The inclusion 
criteria were subjects aged 18 to 25, second 
day of menses, regular menstrual cycle while 
the exclusion criteria were history of anemia, 
use of contraceptive, history of diabetes and 
history of coagulation disorder.  
By 9.00 am, the subjects arrived the 
laboratory and they were allowed to settle 
down. Few minutes after, 6mls of their fasting 
blood samples were collected from the ante 
cubital vein using a 21 G bore needle in a 10 
ml syringe. 2ml of the collected blood sample 
was then injected into a fluoride oxalate bottle 
and the other 4mls into another anticoagulated 
bottle. Thereafter, twenty of them were given 
39 g glucose/200mls of water and the other 
twenty subjects were given 78 g 
glucose/200mls of water. Blood samples were 
again collected from the ante cubital vein 
using a 21 G bore needle in a 10 ml syringe at 
1 hour and 2 hours following the ingestion of 
glucose solution. Blood Sugar was analyzed 
using a colorimeter, Relative Plasma 
Viscosity (RPV) was assessed by a method 
described by Reids and Ugwu (1987) and 
clotting time was assessed using capillary tube 
method.  




Data were presented as mean± standard 
deviation using the Microsoft excel 2010 
analyzed using the student's paired t-test.  
 
Ethics 
Ethical clearance was obtained from 
the Ethics and Collaboration Committee of the 
St Philomena Catholic Hospital where the 
study was done. Informed consent was also 
obtained from the subjects. 
 
RESULTS 
The mean age, height and weight of the 
subjects studied were 21.51±3.97 years, 1.59± 
0.11 m and 59.33±3.33 kg respectively. While 
the age range for menarche and menstrual 
cycle length were 12-14 years and 28-30 years 
respectively. 36 (90%) experienced increased 
use of sanitary pads following ingestion of 
sugar solutions, while 4 (10%) observed no 
change in the number of sanitary pads used. 
None of the subjects experienced an increase 
in the number of days of menstruation 
following ingestion of sugary solutions. 
The mean values for blood sugar  after 
the ingestion of 39 g glucose in 200 ml of 
water and 78 g glucose in 200 ml of water 
were compared to the base line values and the 
blood sugar was found to be higher (p<0.05) 
at the 1 hour post ingestion of glucose 
solution at both concentrations (Table 1). 
However, the difference in blood sugar at 2 
hours post ingestion of both solutions of 
glucose when compared to baseline was not 
statistically significant (p>0.05). 
  
 
Table 1: Blood sugar (BS) levels before and after ingestion of 39 g of glucose/200mls 
water and 78 g of glucose/200 mls water. 
 
BS (mg/dl) before and after  
ingestion of 39 g of glucose/200 mls  
water 
BS (mg/dl) before and 
after ingestion of 78 g of 
glucose/200 mls water 
Time (Hr) 
88.22±4.26 88.18±3.14 0 
144.12±2.13* 161.54±3.33* 1 
91.23±2.86 90.47±2.68 2 
 Superscripts (*) depict significant differences between 0hr or baseline and 1hr and 2hrs after     ingestion of 





Figure 1: Clotting time at 1hr and 2hrs after the ingestion of 39 g of glucose/200 mls. The Clotting 
time value after one hour of the ingestion of 39 g glucose/200mls water during menstruation was significantly higher 
(p<0.05) than the baseline value. Similarly the two hour post ingestion of same concentration was significa tly higher 
(p<0.05) than the baseline value. 
 





Figure 2: Relative plasma viscosity at 1hr and 2hrs after ingestion of 39 g of glucose/200 mls. The 
Relative Plasma Viscosity after  1 hr of  ingestion of 39 g glucose/200mls water during menstruation was significantly higher 






Figure 3: Clotting time at 1hr and 2hrs after ingestion of 78 g of glucose/200 mls H2O. The clotting 
time followed the same pattern as that of ingestion 39 g glucose/200mls of water, despite the higher concentration of 78 g 





Figure 4: Relative Plasma Viscosity at 1hr and 2hrs after ingesting 78 g glucose/200 mls H2O. The 
same pattern for RPV  following ingestion of a lower concentration of glucose was observed i.e. the Relativ  Plasma 
Viscosity after  1 hr of  ingestion of 78 g glucose/200mls water during menstruation was significantly higher (p<0.05)  than  
the baseline. However, the two hour post ingestion value was not statistically different (p>0.05) from the baseline values. 
 




The menstrual cycle is 
characteristically divided into four phases 
with each phase having associated 
hematologic changes (Omorogiuwa and 
Egbeluya, 2014). The phases are menstrual 
follicular, ovulation and luteal. The 
menstruation phase, which is the most obvious 
phase of the cycle, has been observed to be 
affected by sugar intake. However, most 
studies on the effect of sugar on coagulation 
factors have been on diabetic subjects.  For 
instance, Sambola et al. (2003) reported that a 
circulating pool of tissue factor in blood 
associated with cells and microparticles is 
thrombogenic and is elevated in type 2 
diabetes.  
In menstruating girls there is evidence 
suggesting that there is reduction in platelet 
count which explains the increase in bleeding 
time and clotting time (Rajnee et al., 2010). 
Clotting time which is the time taken for 
blood to clot after an injury is a function of 
both platelets and plasma proteins. Plasma is a 
highly concentrated protein solution and its 
viscosity is determined basically by water 
content and macromolecular component of 
blood (Gabor et al., 2008). Among the plasma 
proteins, fibrinogen is the major determinant 
of plasma viscosity (Erdal et al., 2010). 
Results from this study showed a significant 
increase in clotting time during menstruation 
in accordance with a previous work done on 
this subject (Rajnee et al., 2010). The rise in 
clotting time in addition to the decrease in 
relative plasma viscosity from the ingestion of 
glucose may have increased the menstrual 
blood flow. Furthermore, acute hyperglycemia 
increases muscle blood flow and alters 
endothelia function in adolescents with type 1 
diabetes (Amanda et al., 2012).  
Menstrual endometrial breakdown 
induced by estradiol and progesterone 
withdrawal is regularly attributed to a 
sequence of vasospasm of the endometrial 
spiral arteries (Pauline et al., 2013), 
vasodilation in these vessels, increased blood 
flow and increased fibrinolytic activity. 
Although studies have shown that 
hyperglycemia in daibetics increases plasma 
fibrinogen levels, relativeplasma viscosity, 
blood viscosity and coagulability (Carr, 2001; 
Edem et al., 2010;  Lemkes et al., 2010), the 
increase fibrinolytic activity of menstruation 
may have countered the hypercoagualable 
state of the induced acute hyperglycemia,  
consequently, reducing plasma viscosity and 
increasing clotting time (Figures1, 2, 3, 4). 
The increase in clotting time during 
menstruation is as a result of the reduced 
platelet count (Rajnee et al., 2010). 
Nevertheless, the view on the effect of blood 
sugar on clotting time is divergent as Moreno 
et al. (2000) and Vijender (2006) revealed that 
sugar decreases the clotting time in the body.   
 
Conclusion  
From this study, the reduction in 
plasma viscosity increased clotting time and 
the increased endothelial blood flow following 
acute hyperglycemia may explain the 
increased menstrual flow experienced by the 
subjects. Since findings from this research 
suggest that glucose intake can lead to 
increase in clotting time and decrease in 
relative plasma viscosity with a perceived 
increased in menstrual blood flow, we 
recommend that females should reduce 
glucose intake during menstruation. 
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